Adan Sosa, Pharm.D.
Tampa,FL
Summary
As a HEOR Liaison I support the development, dissemination, and generation of real world evidence on behalf of the BMS product portfolio. I have over 20 years of experience working in managed care and industry.
My passion is to advance the utilization of HEOR data by differentiating therapeutic products in an extremely competitive pharmaceutical market. Also, I have a proven track record of working collaboratively with cross functional matrix partners, key thought leaders, and formulary access decision makers.
Overview
26
26
years of professional experience
Work History
Director, Health Economics and Outcomes Research
Bristol Myers Squibb
Princeton-Pike, NJ
06.2021 - Current
- Customer facing role for regional payers, IDN, and health systems in FL, GA, AL, and NC
- Provided comprehensive scientific, health economic, epidemiology, and quality of life presentations to payers/health systems
- Gathered HEOR related customer insights from payers, access opinion leaders, and formulary decision makers
- BMS/Pfizer NVAF strategy and CV advisory board planning committee(s)
- Worked as the HEOR liaison with key thought leaders and home office for a Reblozyl observational research project (Duke, Miami Cancer Inst. and Emory)
- Collaborated with the matrix team on the development and implementation of HEOR strategy, plans, and research projects (Orencia)
- Consulted with payers/health systems for budget planning by demonstrating the Multiple Myeloma Budget Impact Model for micro-costing treatment related adverse events
- Highlighted ethnic differences in patient outcomes for Multiple Myeloma patients receiving Abecma vs. Standard of Care therapy with access opinion leadership at various health systems
- Presented real world outcomes, pre-approval information exchange, and gathered clinical insights on a proposed FDA label for Reblozyl (pre-PDUFA)
- Consulted on risk mitigation for improving patient outcomes and reduced economic burden with earlier treatment of Pomalyst (2L) in RRMM
- Worked with health systems identifying social determinants of health and barriers leading to inequities on patient outcomes
Director Health Economics and Outcomes Research
Sunovion Pharmaceuticals
Marlboro, MA
09.2016 - 06.2021
- Trained Sunovion MSL/HEOR staff on economic burden, quality of life, the impact of drug utilization on payers and patient outcomes
- Reviewed HEOR data most relevant to business topics, and the unintended negative consequences on patient outcomes when payers restrict formulary access
- Provided health systems quality and utilization management teams with educational seminars on CNS disease state and treatment options
- Increased utilization of the Sunovion 360 support tool among payers and health systems to identify under treated bipolar depression and schizophrenia patients
- Developed relationships with key population health decision makers resulting in improved Latuda access in FL, GA, SC, NC, VT, WV (Medicaid)
- Detailed risk mitigation strategies to reduce rehospitalization and overall health resource utilization burden in mental health for payers/health systems
- Worked with the State of Florida Medicaid program to identify inappropriately or under treated bipolar depression patients (non-branded HEOR review)
Senior Medical Science Liaison
EMD Serono
Rockland, MA
03.2012 - 08.2016
- Documented scientific exchange with resulting investigator-initiated studies (IIS), drug utilization tools, and budget impact models for Neurodegenerative Disease
- Outcomes Based Contract (OBC) research support while measuring relapse rates and adherence at Cigna and Humana
- Cultivated cross collaboration with the Global Division at EMD Serono as project lead for the Growth Hormone Waste Calculator
- Collaborated on the development of a Kantar Health Questionnaire for patient treatment preferences data
- Worked with the MS Analyzer tool in identifying patient adherence and outcomes with Med Impact, Geisinger Health, Fairview PBM, Scott and White, and Blue Cross (LA, SC, NJ)
Managed Care/Payer Experience
Pharmacy Director/MCO
Denver, CO
07.1997 - 08.2016
- Ortho McNeil Jansen (Managed Care MSL)
- Great West Healthcare (Pharmacy Director)
- Health Plan of Nevada (Prior Authorization Dept)
Education
Doctor of Pharmacy -
University of Florida
Gainesville, FL12.2009
Bachelor of Science - Pharmacy
University of Colorado At Boulder
Boulder, CO05.1995
Skills
- HEOR strategy, initiatives, and research
- Payers, IDN, ACO, Health Systems
- Customer relationship management
- Portfolio product management (CV, hematology/oncology)
- Data analysis and evidence generation
- Presentation Skills, data dissemination
Work Availability
monday
tuesday
wednesday
thursday
friday
saturday
sunday
morning
afternoon
evening
swipe to browse
Quote
"The credit belongs to the man who is actually in the arena..."
Theodore Roosevelt ~ Man in the Arena
Timeline
Director, Health Economics and Outcomes Research
Bristol Myers Squibb
06.2021 - Current
Director Health Economics and Outcomes Research
Sunovion Pharmaceuticals
09.2016 - 06.2021
Senior Medical Science Liaison
EMD Serono
03.2012 - 08.2016
Managed Care/Payer Experience
Pharmacy Director/MCO
07.1997 - 08.2016
Doctor of Pharmacy -
University of Florida
Bachelor of Science - Pharmacy
University of Colorado At Boulder